Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer

Clinical Cancer Research

Volumn 14, Issue 22, 2008, Pages 7545-7553

  Walther, Wolfgang ^a   Siegel, Robert ^a   Kobelt, Dennis ^a   Knösel, Thomas ^a   Dietel, Manfred ^a   Bembenek, Andreas ^a   Aumann, Jutta ^a   Schleef, Martin ^b   Baier, Ruth ^b   Stein, Ulrike ^a   Schlag, Peter M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Dept Process Development   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PLASMID DNA; MESSENGER RNA;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN TISSUE; JET INJECTION; MALE; MELANOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN METASTASIS; BREAST TUMOR; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LACTOSE OPERON; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; FEMALE; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, JET; LAC OPERON; MALE; MELANOMA; MIDDLE AGED; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 58149337433     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0412     Document Type: Article

References (42)

1. Pike-Overzet K, van der Burg M, Wagemaker G, van Dongen JJ, Staal FJ. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol Ther 2007;15:1910-6.
2. Romano G. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand? Drug News Perspect 2006;19:99-106.
3. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007 - an update. J Gene Med 2007;9:833-42.
4. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
5. Herweijer H, Wolff JA. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 2003;10:453-8.
6. Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004;11:1363-9.
7. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Ther 2002;9:1321-5.
8. Bureau MF, Naimi S, Torero Ibad R, et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004;1676:138-48.
9. McCreery TP, Sweitzer RH, Unger EC, Sullivan S. DNA delivery to cells in vivo by ultrasound. Methods Mol Biol 2004;245:293-8.
10. Rakhmilevich AL, Turner J, Ford MJ, et al. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci U S A 1996;93:6291-6.
11. Sikes ML, O'Malley BW, Jr., Finegold MJ, Ledley FD. In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. Hum Gene Ther 1994;5:837-44.
12. Somiari S, Glasspool-Malone J, Drabick JJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000;2:178-87.
13. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990;87:9568-72.
14. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999;6:1258-66.
15. Furth PA, Kerr D, Wall R. Gene transfer by jet injection into differentiated tissues of living animals and in organ culture. Mol Biotechnol 1995;4:121-7.
16. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002;9:1647-52.
17. Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther 2000;7:31-4.
18. Walther W, Stein U, Fichtner I, Malcherek L, Lemm M, Schlag PM. Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther 2001;8:173-80.
19. Sawamura D, Ina S, Itai K, et al. In vivo gene introduction into keratinocytes using jet injection. Gene Ther 1999;6:1785-7.
20. Ren S, Li M, Smith JM, DeTolla LJ, Furth PA. Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol 2002;2:10.
21. Walther W, Minow T, Martin R, Fichtner I, Schlag PM, Stein U. Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection. Hum Gene Ther 2006;17:611-24.
22. Walther W, Stein U, Fichtner I, et al. Nonviral jet-injection gene transfer for efficient in vivo cytosine deaminase suicide gene therapy of colon carcinoma. Mol Ther 2005;12:1176-84.
23. Walther W, Arlt F, Fichtner I, Aumann J, Stein U, Schlag PM. Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter-regulated tumor necrosis factor-α expression. Mol Cancer Ther 2007;6:236-43.
24. Schleef M, Schmidt T, Flaschel E. Plasmid DNA for pharmaceutical applications. Dev Biol (Basel) 2000;104:25-31.
25. Schleef M, Schmidt T. Animal-free production of ccc-supercoiled plasmids for research and clinical applications. J Gene Med 2004;6 Suppl 1:S45-53.
26. Walther W, Stein U, Voss C, Schmidt T, Schleef M, Schlag PM. Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer. Anal Biochem 2003;318:230-5.
27. Heinzerling L, Burg G, Dummer R, et al. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther 2005;16:35-48.
28. Timmerman JM, Singh G, Hermanson G, et al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Cancer Res 2002;62:5845-52.
29. Shergold OA, Fleck NA, King TS. The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. J Biomech 2006;39:2593-602.
30. Zhang G, Gao X, Song YK, et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther 2004;11:675-82.
31. Schramm-Baxter J, Mitragotri S. Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release 2004;97:527-35.
32. Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 2006;5:543-8.
33. Arora A, Hakim I, Baxter J, et al. Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc Natl Acad Sci U S A 2007;104:4255-60.
34. Hickman MA, Malone RW, Lehmann-Bruinsma K, et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994;5:1477-83.
35. O'Hara AJ, Howell JM, Taplin RH, et al. The spread of transgene expression at the site of gene construct injection. Muscle Nerve 2001;24:488-95.
36. Kuball J, Wen SF, Leissner J, et al. Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. J Clin Oncol 2002;20:957-65.
37. Lang FF, Bruner JM, Fuller GN, et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003;21:2508-18.
38. Morishita R, Aoki M, Hashiya N, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004;44:203-9.
39. Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998;16:2221-32.
40. Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release 2002;78:259-66.
41. Gottesman MM. Cancer gene therapy: an awkward adolescence. Cancer Gene Ther 2003;10:501-8.
42. Walther W, Stein U, Schlag PM. Local gene therapy for cancer. In: Schlag PM, Stein U, editors. Regional cancer therapy. Totowa (NJ): Humana Press; 2007. p.181-96.